Moving to value-based payment models and comparative effectiveness analysis is expected to improve the ability to treat patients in a more clinically and cost-effective manner.
The hope is that the focus on moving to more valuebased payment models will begin to bring in more measures of the effects this has on patient outcomes, which are the most important measure of the effects of changes in the use of health care services. That, along with the focus on comparative effectiveness analysis, which attempts to provide information on the differential clinical effects of using various interventions and treatment agents on different types of patients, should improve the ability to treat patients in a more clinically and cost-effective manner.
Plante et al. (Thu,) reported a editorial. Moving to value-based payment models and comparative effectiveness analysis is expected to improve the ability to treat patients in a more clinically and cost-effective manner.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: